LASA SUPERGENERICS
Back to Income Statement
|
LASA SUPERGENERICS Last 5 Year Revenue History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Net Sales | ₹104 Cr | ₹130 Cr | ₹137 Cr | ₹202 Cr | ₹167 Cr |
What is the latest Revenue of LASA SUPERGENERICS ?
| Year | Revenue |
|---|---|
| Mar2024 | ₹104 Cr |
| Mar2023 | ₹130 Cr |
| Mar2022 | ₹137 Cr |
| Mar2021 | ₹202 Cr |
| Mar2020 | ₹167 Cr |
How is Revenue of LASA SUPERGENERICS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2024 | ₹104 Cr | -19.47 | |
| Mar2023 | ₹130 Cr | -5.51 | |
| Mar2022 | ₹137 Cr | -32.24 | |
| Mar2021 | ₹202 Cr | 21.00 | |
| Mar2020 | ₹167 Cr | - | |
Compare Revenue of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹38.7 Cr | -2.4% | -5% | -55.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,121.0 Cr | 3.2% | 12.5% | 10.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,396.0 Cr | 2.9% | 8.5% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,730.0 Cr | 0.3% | 5.7% | 36.3% | Stock Analytics | |
| CIPLA | ₹115,241.0 Cr | 10.4% | 15.9% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,126.0 Cr | 4.8% | 9% | 10.8% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -2.4% |
-5% |
-55.2% |
| SENSEX | -0.9% |
-3.6% |
-8.6% |
You may also like the below Video Courses